Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging

Chieh Hsin Lin, Hui Ting Yang, Chih Chiang Chiu, Hsien Yuan Lane

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Feasible peripheral biomarker for Alzheimer's disease (AD) is lacking. Dysregulation of N-methyl-D-aspartate (NMDA) receptor is implicated in the pathogenesis of AD. D-amino acid oxidase (DAO) and amino acids can regulate the NMDA receptor function. This study aimed to examine whether peripheral DAO and amino acids levels are characteristic of age-related cognitive decline. We enrolled 397 individuals (including amnestic mild cognitive impairment (MCI), mild AD, moderate to severe AD, and healthy elderly). DAO levels in the serum were measured using ELISA. Amino acids levels in serum were measured by high performance liquid chromatography. Severity of the cognitive deficits in subjects was assessed using Clinical Dementia Rating Scale (CDR). The DAO levels increased with the severity of the cognitive deficits. DAO levels were significantly associated with D-glutamate and D-serine levels. The Receiver Operating Characteristics analysis of DAO levels for AD patients vs. healthy controls determined the optimal cutoff value, 30.10, with high sensitivity (0.842) and specificity (0.889) (area under curve = 0.928). This is the first study indicating that the peripheral DAO levels may increase with age-related cognitive decline. The finding supports the hypofunction of NMDA receptor hypothesis in AD. Whether DAO could serve as a potential surrogate biomarker needs further studies.

Original languageEnglish
Article number14849
JournalScientific Reports
Volume7
Issue number1
DOIs
Publication statusPublished - Dec 1 2017
Externally publishedYes

Fingerprint

D-Amino-Acid Oxidase
Amino Acids
Alzheimer Disease
N-Methyl-D-Aspartate Receptors
Biomarkers
Cognitive Aging
Serum
ROC Curve
Serine
Area Under Curve
Dementia
Glutamic Acid
Enzyme-Linked Immunosorbent Assay
High Pressure Liquid Chromatography
Sensitivity and Specificity

ASJC Scopus subject areas

  • General

Cite this

Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging. / Lin, Chieh Hsin; Yang, Hui Ting; Chiu, Chih Chiang; Lane, Hsien Yuan.

In: Scientific Reports, Vol. 7, No. 1, 14849, 01.12.2017.

Research output: Contribution to journalArticle

Lin, Chieh Hsin ; Yang, Hui Ting ; Chiu, Chih Chiang ; Lane, Hsien Yuan. / Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{2a621599d0e54dc1bca91ea2f39e5e91,
title = "Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging",
abstract = "Feasible peripheral biomarker for Alzheimer's disease (AD) is lacking. Dysregulation of N-methyl-D-aspartate (NMDA) receptor is implicated in the pathogenesis of AD. D-amino acid oxidase (DAO) and amino acids can regulate the NMDA receptor function. This study aimed to examine whether peripheral DAO and amino acids levels are characteristic of age-related cognitive decline. We enrolled 397 individuals (including amnestic mild cognitive impairment (MCI), mild AD, moderate to severe AD, and healthy elderly). DAO levels in the serum were measured using ELISA. Amino acids levels in serum were measured by high performance liquid chromatography. Severity of the cognitive deficits in subjects was assessed using Clinical Dementia Rating Scale (CDR). The DAO levels increased with the severity of the cognitive deficits. DAO levels were significantly associated with D-glutamate and D-serine levels. The Receiver Operating Characteristics analysis of DAO levels for AD patients vs. healthy controls determined the optimal cutoff value, 30.10, with high sensitivity (0.842) and specificity (0.889) (area under curve = 0.928). This is the first study indicating that the peripheral DAO levels may increase with age-related cognitive decline. The finding supports the hypofunction of NMDA receptor hypothesis in AD. Whether DAO could serve as a potential surrogate biomarker needs further studies.",
author = "Lin, {Chieh Hsin} and Yang, {Hui Ting} and Chiu, {Chih Chiang} and Lane, {Hsien Yuan}",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-13951-7",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging

AU - Lin, Chieh Hsin

AU - Yang, Hui Ting

AU - Chiu, Chih Chiang

AU - Lane, Hsien Yuan

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Feasible peripheral biomarker for Alzheimer's disease (AD) is lacking. Dysregulation of N-methyl-D-aspartate (NMDA) receptor is implicated in the pathogenesis of AD. D-amino acid oxidase (DAO) and amino acids can regulate the NMDA receptor function. This study aimed to examine whether peripheral DAO and amino acids levels are characteristic of age-related cognitive decline. We enrolled 397 individuals (including amnestic mild cognitive impairment (MCI), mild AD, moderate to severe AD, and healthy elderly). DAO levels in the serum were measured using ELISA. Amino acids levels in serum were measured by high performance liquid chromatography. Severity of the cognitive deficits in subjects was assessed using Clinical Dementia Rating Scale (CDR). The DAO levels increased with the severity of the cognitive deficits. DAO levels were significantly associated with D-glutamate and D-serine levels. The Receiver Operating Characteristics analysis of DAO levels for AD patients vs. healthy controls determined the optimal cutoff value, 30.10, with high sensitivity (0.842) and specificity (0.889) (area under curve = 0.928). This is the first study indicating that the peripheral DAO levels may increase with age-related cognitive decline. The finding supports the hypofunction of NMDA receptor hypothesis in AD. Whether DAO could serve as a potential surrogate biomarker needs further studies.

AB - Feasible peripheral biomarker for Alzheimer's disease (AD) is lacking. Dysregulation of N-methyl-D-aspartate (NMDA) receptor is implicated in the pathogenesis of AD. D-amino acid oxidase (DAO) and amino acids can regulate the NMDA receptor function. This study aimed to examine whether peripheral DAO and amino acids levels are characteristic of age-related cognitive decline. We enrolled 397 individuals (including amnestic mild cognitive impairment (MCI), mild AD, moderate to severe AD, and healthy elderly). DAO levels in the serum were measured using ELISA. Amino acids levels in serum were measured by high performance liquid chromatography. Severity of the cognitive deficits in subjects was assessed using Clinical Dementia Rating Scale (CDR). The DAO levels increased with the severity of the cognitive deficits. DAO levels were significantly associated with D-glutamate and D-serine levels. The Receiver Operating Characteristics analysis of DAO levels for AD patients vs. healthy controls determined the optimal cutoff value, 30.10, with high sensitivity (0.842) and specificity (0.889) (area under curve = 0.928). This is the first study indicating that the peripheral DAO levels may increase with age-related cognitive decline. The finding supports the hypofunction of NMDA receptor hypothesis in AD. Whether DAO could serve as a potential surrogate biomarker needs further studies.

UR - http://www.scopus.com/inward/record.url?scp=85032806558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032806558&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-13951-7

DO - 10.1038/s41598-017-13951-7

M3 - Article

AN - SCOPUS:85032806558

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 14849

ER -